Welcome to the website for:

The United Kingdom Transcatheter Aortic Valve Implantation (UK TAVI) Trial

The UK TAVI trial is a multi-centre randomised controlled trial to assess the clinical effectiveness

and cost-utility of UK TAVI, compared with conventional surgical aortic valve replacement, in patients

with severe symptomatic aortic stenosis, who are at intermediate or high operative risk.  

If you require any further information, please contact:

Dr William D. Toff
Senior Lecturer in Cardiology

Department of Cardiovascular Sciences
University of Leicester

Tel: +44 (0)116 250 2500 | Fax: +44 (0)116 250 2501 | e-mail: w.toff@le.ac.uk

Department of Cardiovascular Sciences, University of Leicester
Clinical Sciences Wing, Glenfield Hospital, Groby Road, Leicester LE3 9QP United Kingdom

General Data Protection Regulations (GDPR):

The University of Leicester is the sponsor for this study based in the United Kingdom. We will be using information from you and/or your medical records in order to undertake this study and will act as the data controller for this study. This means that we are responsible for looking after your information and using it properly. The University of Leicester will keep identifiable information about you for at least 5 years after the study has finished.

Your rights to access, change or move your information are limited, as we need to manage your information in specific ways in order for the research to be reliable and accurate. If you withdraw from the study, we will keep the information about you that we have already obtained. To safeguard your rights, we will use the minimum personally-identifiable information possible.

You can find out more about how we use your information here: https://www2.le.ac.uk/colleges/medbiopsych/research/researchgovernance or by emailing uolsponsor@leicester.ac.uk

Additional GDPR Guidance for Researchers is available here: https://www2.le.ac.uk/colleges/medbiopsych/research/ctu/gdpr-for-research